Héctor Huerga Encabo
Location
Barcelona
Description
Before joining the CaixaResearch Institute, he worked at the Francis Crick Institute as a postdoctoral researcher in the laboratory of Dominique Bonnet. During this time, he demonstrated that certain mutations evolve in response to environmental stresses and alter the development of innate immune cells, such as neutrophils and monocytes. Building on this work, his group investigates potential markers that may help predict which individuals could develop conditions such as cancer or cardiovascular diseases.
His research, published in journals such as Cell Stem Cell, Blood, The New England Journal of Medicine, Nature Immunology and The Journal of Experimental Medicine, has helped to redefine the role of haematopoietic stem cells in health and disease. Huerga Encabo has been recognised with international fellowships such as the Kay Kendall Leukaemia Fund Fellowship, as well as grants from the European Haematology Association and Cancer Research UK.
Dr. Josep Dalmau
Neurologist specialised in neuro-oncology, PhD in Medicine,and senior group leader at the CaixaResearch Institute
After graduating with a degree and completing his PhD in Medicine at the Universitat Autònoma de Barcelona, Josep Dalmau specialised in neurology and trained in neuro-oncology at the Memorial Sloan Kettering Cancer Center in New York. He has spent a ...
Dr. Gabriel Rabinovich
Biochemist, PhD in Immunology, senior group leader at the CaixaResearch Institute and cofounder of Galtec
After graduating in Biochemistry from the University of Córdoba (Argentina) and specialising in Molecular Biology at the Kennedy Institute of Rheumatology in London, Gabriel Rabinovich obtained his PhD in Immunology from the University of Córdoba. ...
Dr. Gemma Moncunill
Biologist, PhD in Immunology, and consolidated group leader at the CaixaResearch Institute
Gemma Moncunill holds a PhD in Immunology from the Universitat Autònoma de Barcelona. She trained at leading international institutions such as the Fred Hutchinson Cancer Research Center (Seattle) and the University of British Columbia (Vancouver). ...